Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:ratio of apoptotic bodies to intact tumor cells in nonremodelling liver tumorous lesions
go back to main search page
Accession:CMO:0002173 term browser browse the term
Definition:A calculated measurement in which the number of apoptotic bodies found in a specified sample of nonremodelling liver tumorous lesions is divided by the number of viable neoplastic hepatocytes in the same sample, and the result presented as a ratio, fraction, quotient or percentage. Nonremodeling tumorous lesions are lesions which are or have the potential to become tumors (neoplasms or new growths of tissue in which cell multiplication is more or less uncontrolled and progressive) without any indication of a remodeling phenotype, that is, without a decrease in biochemical marker expression or growth rate, and without signs of regression. An apoptotic body is a small sealed membrane vesicle that is produced from cells undergoing cell death by apoptosis.
Synonyms:related_synonym: ratio of apoptotic bodies to intact tumor cells in nonremodelling liver neoplastic nodules


show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "ratio of apoptotic bodies to intact tumor cells in nonremodelling liver tumorous lesions" (CMO:0002173)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    cell measurement 24
      apoptotic cell measurement 0
        calculated apoptotic cell measurement 0
          calculated apoptotic body measurement 0
            ratio of apoptotic bodies to intact tumor cells in nonremodelling liver tumorous lesions 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        liver lesion measurement 29
          liver tumorous lesion measurement 29
            calculated liver tumorous lesion measurement 8
              ratio of apoptotic bodies to intact tumor cells in nonremodelling liver tumorous lesions 0
paths to the root